Nachrichten zur iRhythm Technologies Aktie

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of iRhythm Technologies, Inc. - IRTC

CEDARHURST, N.Y., Feb. 28, 2024 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

IRHYTHM SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTC

NEW ORLEANS, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm

NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ROSEN, SKILLED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRTC

NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Earnings call: iRhythm Technologies reports 20% revenue growth By Investing.com

Earnings call: iRhythm Technologies reports 20% revenue growth…

iRhythm Technologies, Inc. (IRTC) Q4 2023 Earnings Call Transcript

…

iRhythm Technologies, Inc. 2023 Q4 - Results - Earnings Call Presentation

…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC)

LOS ANGELES, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of iRhythm Technologies, Inc. - IRTC

CEDARHURST, N.Y., Feb. 21, 2024 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues…

Investors who lost money on iRhythm Technologies, Inc. (IRTC) should contact The Gross Law Firm about pending Class Action - IRTC

NEW YORK, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

IRHYTHM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTC

NEW ORLEANS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm

NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, and Xponential and Encourages Investors to Contact the Firm

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

2 Biggest Medical Device ETFs in 2024

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC

NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRTC

NEW YORK, Feb. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

IRTC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…

iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union gemäß Medizinprodukteverordnung (EU-MDR) für Zio®-Monitor und ZEUS-System

Die CE-Kennzeichnung unterstreicht die führende Rolle des Zio-Monitorsystems bei der ambulanten Herzüberwachung und unterstreicht das Engagement des Unternehmens, weltweit Produkte…

GNW-Adhoc: iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union gemäß Medizinprodukteverordnung (EU-MDR) für Zio®-Monitor und ZEUS-System

^SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (https://www.irhythmtech.com/) (NASDAQ:IRTC), ein führendes Unternehmen im Bereich…

GNW-Adhoc: iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union gemäß Medizinprodukteverordnung (EU-MDR) für Zio®-Monitor und ZEUS-System

^SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (https://www.irhythmtech.com/) (NASDAQ:IRTC), ein führendes Unternehmen im Bereich der digitalen…

GNW-Adhoc: iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union gemäß Medizinprodukteverordnung (EU-MDR) für Zio®-Monitor und ZEUS-System

^SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (https://www.irhythmtech.com/) (NASDAQ:IRTC), ein führendes Unternehmen im Bereich…

GNW-Adhoc: iRhythm Technologies erhält CE-Kennzeichnung der Europäischen Union gemäß Medizinprodukteverordnung (EU-MDR) für Zio®-Monitor und ZEUS-System

^SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc.(https://www.irhythmtech.com/) (NASDAQ:IRTC), ein führendes Unternehmen imBereich der digitalen Gesundheit, das…

Global Holter Monitor Market Insights Report 2024-2029 Featuring Key Vendors - GE Healthcare, Koninklijke Philips, iRhythm Technologies, Hill-Rom, Nihon Kohden, & Fukuda Denshi

Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Holter Monitor Market - Focused Insights 2024-2029" report has…

iRhythm Technologies, Inc. (IRTC) Q3 2023 Earnings Call Transcript

…

iRhythm Technologies, Inc. 2023 Q3 - Results - Earnings Call Presentation

…

iRhythm climbs as Q2 tops estimates despite regulatory setback

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q iRhythm Technologies, For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

iRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023

SAN FRANCISCO, July 20, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company…

iRhythm is new Outperform at Baird despite FDA warning letter

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K iRhythm Technologies, For: Jun 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K iRhythm Technologies, For: Jun 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

iRhythm receives FDA warning letter on California plant inspection

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K iRhythm Technologies, For: May 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

Clinical studies presented at Heart Rhythm 2023 build on the totality of clinical evidence that continue to highlight the value…

iRhythm Technologies to Report First Quarter 2023 Financial Results on May 4, 2023

SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company…

iRhythm Technologies Releases 2022 Environmental, Social, and Governance Report Reflecting Strategy to Deliver Purpose-Driven Growth

SAN FRANCISCO, April 12, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused…

dpa-AFX ProFeed